0001209191-23-004144.txt : 20230119 0001209191-23-004144.hdr.sgml : 20230119 20230119214538 ACCESSION NUMBER: 0001209191-23-004144 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230117 FILED AS OF DATE: 20230119 DATE AS OF CHANGE: 20230119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alrutz Michael Albert CENTRAL INDEX KEY: 0001422345 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35867 FILM NUMBER: 23538777 MAIL ADDRESS: STREET 1: 2530 MERIDIAN PARKWAY STREET 2: 2ND FLOOR CITY: DURHAM STATE: NC ZIP: 27713 FORMER NAME: FORMER CONFORMED NAME: Alrutz Michael A DATE OF NAME CHANGE: 20080102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHIMERIX INC CENTRAL INDEX KEY: 0001117480 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330903395 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 919.806.1074 MAIL ADDRESS: STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100 CITY: DURHAM STATE: NC ZIP: 27713 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-17 0 0001117480 CHIMERIX INC CMRX 0001422345 Alrutz Michael Albert C/O CHIMERIX, INC. 2505 MERIDIAN PARKWAY, SUITE 340 DURHAM NC 27713 0 1 0 0 Principal Executive Officer Common Stock 2023-01-17 4 A 0 21450 0.00 A 142015 D Stock Option (Right to Buy) 1.97 2023-01-17 4 A 0 128550 0.00 A 2033-01-16 Common Stock 128550 128550 D The shares being reported are being issued pursuant to restricted stock unit awards ("RSUs"), each one of which represents a contingent right to receive one share of the Issuer's common stock. 5,362 shares subject to the RSUs will vest on the one-year anniversary of the date of grant, 5,362 shares subject to the RSUs will vest on the second-year anniversary of the date of grant, 5,362 shares subject to the RSUs will vest on the third-year anniversary of the date of grant, and 5,364 shares subject to the RSUs will vest on the fourth-year anniversary of the date of grant. Includes 1,022 shares acquired under the Issuer's Employee Stock Purchase Plan on September 9, 2022. 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant. /s/ Michael Alrutz 2023-01-19